Search Results - "Tarpin, C"

Refine Results
  1. 1
  2. 2

    Effects of termite sheetings on soil properties under two contrasting soil management practices by Lejoly, J., Cornelis, J.-T., Van Ranst, E., Jansegers, E., Tarpin, C., Degré, A., Colinet, G., Malaisse, F.

    Published in Pedobiologia (01-09-2019)
    “…•Termite sheetings substantially improved soil properties.•Termite activity sequester organic matter in sheetings.•Termite activity improves soil properties in…”
    Get full text
    Journal Article Web Resource
  3. 3

    Investigating sexual health after breast cancer by longitudinal assessment of patient-reported outcomes by Franzoi, M.A., Aupomerol, M., Havas, J., Soldato, D., Lambertini, M., Massarotti, C., Hang, H., Pistilli, B., Fasse, L., Tredan, O., Gillanders, E., Joly, F., Cottu, P., Mouret-Reynier, M.-A., Tarpin, C., Arnaud, A., Everhard, S., Martin, A.-L., Di Meglio, A., Vaz-Luis, I.

    Published in ESMO open (01-02-2024)
    “…Sexual concerns are a major unaddressed need among survivors of breast cancer (BC) with significant negative effects on quality of life. We longitudinally…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Buccodental side effects of sunitinib in patients with metastatic renal cell carcinoma by Gilabert, M, Provansal, M, Cappiello, M, Walz, Y, Salem, N, Tarpin, C, Brunelle, S, Thomassin, J, Gravis, G

    Published in British journal of cancer (01-10-2013)
    “…Background: Sunitinib is a tyrosine kinase inhibitor approved for the treatment of renal cell carcinoma (RCC). Few data evaluated severe buccodental adverse…”
    Get full text
    Journal Article
  6. 6

    Factors associated with enrolment in clinical trials among women with early-stage breast cancer by Presti, D., Havas, J., Soldato, D., Lapidari, P., Martin, E., Pistilli, B., Jouannaud, C., Emile, G., Rigal, O., Fournier, M., Soulie, P., Mouret-Reynier, M.-A., Tarpin, C., Campone, M., Guillermet, S., Martin, A.-L., Everhard, S., Di Meglio, A.

    Published in ESMO open (01-06-2022)
    “…Clinical trials allow development of innovative treatments and ameliorate the quality of clinical care in oncology. Data show that only a minority of patients…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Participants' uptake of clinical trial results: a randomised experiment by Mancini, J, Genre, D, Dalenc, F, Ferrero, J-M, Kerbrat, P, Martin, A-L, Roché, H, Maylevin, F, Tarpin, C, Viens, P, Genève, J, Julian-Reynier, C

    Published in British journal of cancer (30-03-2010)
    “…Background: Participants are showing great interest these days in obtaining the results of clinical trials. The aim of this study was to assess patients’…”
    Get full text
    Journal Article
  10. 10

    Quality of life in a heterogeneous sample of caregivers of cancer patients: an in-depth interview study by MANCINI, J., BAUMSTARCK-BARRAU, K., SIMEONI, M.-C., GROB, J.-J., MICHEL, G., TARPIN, C., LOUNDOU, A.-D., LAMBERT, A., CLÉMENT, A., AUQUIER, P.

    Published in European journal of cancer care (01-07-2011)
    “…MANCINI J., BAUMSTARCK‐BARRAU K., SIMEONI M.‐C., GROB J.‐J., MICHEL G., TARPIN C., LOUNDOU A.‐D., LAMBERT A., CLÉMENT A. & AUQUIER P. (2010) European Journal…”
    Get full text
    Journal Article
  11. 11

    High-dose Alkylating Agents with Autologous Hematopoietic Stem Cell Support and Trastuzumab in ERBB2 Overexpressing Metastatic Breast Cancer: A Feasibility Study by GONCALVES, A, BRAUD, A. C, VIRET, F, TARPIN, C, CHARAFFE-JAUFFRET, E, JACQUEMIER, J, MARANINCHI, D, VIENS, P

    Published in Anticancer research (01-01-2005)
    “…Background: ERBB2 overexpression predicts a worse outcome for patients receiving high-dose chemotherapy (HDC). Trastuzumab improves response rate and survival…”
    Get full text
    Journal Article
  12. 12

    Phase I study of pegylated liposomal doxorubicin (Caelyx) in combination with carboplatin in patients with advanced solid tumors by Gonçalves, A, Braud, A C, Viret, F, Genre, D, Gravis, G, Tarpin, C, Giovannini, M, Maraninchi, D, Viens, P

    Published in Anticancer research (01-07-2003)
    “…To determine the maximum tolerated dose of the combination of Carboplatin and Caelyx, a pegylated liposomal doxorubicin, with promising activities in various…”
    Get more information
    Journal Article
  13. 13

    Multivariate analysis of survival in inflammatory breast cancer: impact of intensity of chemotherapy in multimodality treatment by BERTUCCI, F, TARPIN, C, BLAISE, D, JACQUEMIER, J, MARANINCHI, D, VIENS, P, CHARAFE-JAUFFRET, E, BARDOU, V-J, BRAUD, A-C, TALLET, A, GRAVIS, G, VIRET, F, GONCALVES, A, HOUVENAEGHEL, G

    Published in Bone marrow transplantation (Basingstoke) (01-05-2004)
    “…The prognosis of inflammatory breast cancer (IBC) is poor. We evaluated clinical and biopathological characteristics that could affect survival in 74 women…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20